Copyright: ©Author(s) 2026. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution-NonCommercial (CC BY-NC 4.0) license. No commercial re-use. See permissions. Published by Baishideng Publishing Group Inc.
World J Psychiatry. Dec 19, 2026; 16(12): 118405
Published online Dec 19, 2026. doi: 10.5498/wjp.118405
Published online Dec 19, 2026. doi: 10.5498/wjp.118405
Non-motor symptomatology of Parkinson’s disease in an elderly population: The role of depression, anxiety, and fatigue
Eric Michael Kunz, Devon Thomas Foster, Siddharth Jasti, Herbert Wertheim College of Medicine, Florida International University, Miami, FL 33199, United States
Brandon Lucke-Wold, Lillian S. Wells Department of Neurosurgery, University of Florida, Gainesville, FL 32608, United States
Author contributions: Kunz EM and Foster DT designed the overall concept and outline of the manuscript; Foster DT and Jasti S contributed to the discussion and design of the manuscript; Kunz EM and Lucke-Wold B contributed to the writing and editing of the manuscript, and the review of the literature.
Conflict-of-interest statement: The authors have no conflicts of interest to disclose.
Corresponding author: Eric Michael Kunz, Herbert Wertheim College of Medicine, Florida International University, 11200 SW 8th St, Miami, FL 33199, United States. ekunz005@med.fiu.edu
Received: January 5, 2026
Revised: January 29, 2026
Accepted: February 10, 2026
Published online: December 19, 2026
Processing time: 324 Days and 15.9 Hours
Revised: January 29, 2026
Accepted: February 10, 2026
Published online: December 19, 2026
Processing time: 324 Days and 15.9 Hours
Core Tip
Core Tip: Parkinson’s disease (PD) is increasingly defined by non-motor symptoms that profoundly affect patient outcomes. Depression, anxiety, and fatigue form a highly prevalent and interrelated triad, particularly in elderly individuals with PD. Building on previous research results, this paper highlights shared neurobiological mechanisms, identifies clinical and socioeconomic risk modifiers, and emphasizes the relevance of non-motor symptom profiling for treatment planning, including deep brain stimulation. Systematic assessment and integrated management of these symptoms are essential to improving quality of life and optimizing therapeutic decision-making in aging PD populations.